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Abstract: Microalgae and cyanobacteria represent a formidable source of metabolites: some are toxic, but many 
others have potential beneficial applications and are attracting a lot of interest from different industrial sectors (food, 
drugs, cosmetics) seeking for innovative, active and “natural” products. 
Microalgae biomass represents a rich source for discovery. The potential for algae-based ingredients in the industry 
relies on the manipulation and targeting of ingredients to fit increasingly niche product specifications. Microalgae are 
exposed to extreme environment and thus have developed unique mechanism for protection. Furthermore, these 
organisms produce different metabolites which we need to identify and exploit in a sustainable way for the production 
of food, drugs and cosmetics. 
The AlgaeCeuticals project (Project N. 778263, H2020-MSCA-RISE-2017) will take advantage of the native microalgae 
and cyanobacteria strains producing high added value products and through the application of novel omics 
technologies (genomics, metagenomics, transcriptomics, proteomics, enzymomics and metabolomics) as well as algae 
culture technologies and production of novel products. AlgaeCeuticals will screen and characterize microalgal 
biodiversity, develop and optimize algae culture systems, develop omics resources for algae and also develop 
downstream processing strategies and novel products. For this reason and in order to achieve its object, 4 academic 
and research centers from Greece (Centre for Research and Technology Hellas; Agricultural University of Athens), Italy 
(Fondazione Edmund Mach) and Spain (Centro Tecnológico Nacional de la Conserva y Alimentación) will collaborate 
for four years with 3 industrial R&D partners from Greece (Fresh Formula), Spain (Bionos Biotech ND) and Austria 
(Ecoduna AG). Through this collaboration the academic partners will work closely with the industrial R&D and form a 
complementary and highly competitive team that will promote transfer of knowledge and excellence to industrial 
partners. This will strengthen the industrial competitiveness in the field of food and cosmetics in the process of the 
design, development, testing of the products proposed by the project. 
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